Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  MARIO ERNEST
 2. Date of Event Requiring Statement (Month/Day/Year)
04/02/2018		 3. Issuer Name and Ticker or Trading Symbol
Kindred Biosciences, Inc. [KIN]
(Last)
(First)
(Middle)
C/O KINDRED BIOSCIENCES, INC., 1555 BAYSHORE HIGHWAY, SUITE 200		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

BURLINGAME, CA 94010		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 124,167
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (1) 08/28/2023 Common Stock 833 $ 1.37 D  
Stock Option (Right to Buy)   (2) 02/02/2024 Common Stock 37,000 $ 15.41 D  
Stock Option (Right to Buy)   (3) 01/25/2025 Common Stock 44,000 $ 6.96 D  
Stock Option (Right to Buy)   (4) 01/07/2026 Common Stock 44,000 $ 3.45 D  
Stock Option (Right to Buy)   (5) 07/23/2027 Common Stock 20,000 $ 7.65 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
MARIO ERNEST
C/O KINDRED BIOSCIENCES, INC.
1555 BAYSHORE HIGHWAY, SUITE 200
BURLINGAME, CA 94010		   X      

Signatures

/s/ Dietrick Miller, Attorney in Fact 04/11/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The option vested in four equal quarterly installments following the grant date of August 29, 2013.
(2) The option vested in four equal quarterly installments following the grant date of February 3, 2014.
(3) The option vested in four equal quarterly installments following the grant date of January 26, 2015.
(4) The option vested in four equal quarterly installments following the grant date of January 8, 2016.
(5) 10,000 shares subject to the option vested in two equal quarterly installments on October, 24, 2017 and January 24, 2018. The remaining 10,000 shares subject to the option vest in two equal quarterly installments on April 24, 2018 and July 24, 2018.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.